Verve Therapeutics, Inc. (29) | Uncategorized (4)

Recent Contracts

Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 14, 2022)
Offer Letter, dated as of April 16, 2019, by and between the Registrant and Sekar Kathiresan, M.D (Filed With SEC on May 28, 2021)
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Ashe, J.D (Filed With SEC on May 28, 2021)
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Bellinger, M.D., Ph.D (Filed With SEC on May 28, 2021)